Pharmacogenomics for precision medicine
- Submission status
- Open
Healthcare is gradually moving away from a one-size fits all approach to a greater focus on patients as individuals. Precision medicine aims to identify subpopulations of patients that will best respond to specific treatments in order to optimise care. Pharmacogenomics, the study of genome variation in drug response, is a key tool in meeting this aim.
This Collection will present recently identified genomic pathways, novel genetic biomarkers, and epigenetic signals that influence treatment outcomes for particular patient populations.
Editors
-
Mayumi Ueta
Kyoto Prefectural University of Medicine, Japan
-
Wei-Qi Wei
Vanderbilt University Medical Center (VUMC), USA
Collections articles undergo Scientific Reports' standard peer review process and are subject to all of the journal’s standard policies. This includes the journal’s policy on competing interests. The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
This Collection has not been supported by sponsorship.
